Article Listing - Genzyme makes $600 million bid for SangStat; moves into new market

ALBANIAN PHARMA ASSOCIATION

20 April 1992

Albania's Ministry of Health has approved the establishment of the Albanian Pharmaceutical Assoc-iation, reports the ATA news agency. The new...

GERMAN CALL FOR MORE CONTROL OF ACCESS

20 April 1992

German citizens with state health insurance coverage should in future be entitled to access to a medical specialist only after...

BROKER UPGRADES SWISS DRUG MAJORS

20 April 1992

Following recent results from Switzerland's big three chemical/ pharmaceutical groups, Shearson Lehman Brothers' analysts have upgraded their forecasts for the...

HUHTAMAKI OPTIMISM FOR 1991 VINDICATED

20 April 1992

Finland's Huhtamaki said a year ago that it was "cautiously optimistic" about 1991 in the face of the rapidly-worsening situation,...

ROBERTS NCRC DEAL COMPLETE

20 April 1992

Roberts Pharmaceutical of the USA has completed the acquisition of the National Clinical Research Centers in Bethesda, USA (Marketletter April...

J&J IN STOCK REPURCHASE

20 April 1992

Johnson & Johnson is to repurchase up to $500 million of its outstanding common stock for corporate purposes. The company...

AHP DEAL OVER GROWTH HORMONE STIMULATORS

20 April 1992

American Home Products Corp has obtained an exclusive license from Japan's Kaken Pharma to manufacture and market products based on...

HYDRO PHARMA TAKEOVER

20 April 1992

Norwegian pharmaceutical concern Hafslund Nycomed, through its subsidiary Nycomed Pharma, has finalized the takeover of Hydro Pharma (Marketletter February 24)...

SIR ARNOLD BURGEN RETIRES

20 April 1992

Sir Arnold Burgen has retired as a non-executive director of Amersham International, UK.

ZAMBON LAUNCHES ANTAXONE IN SPAIN

20 April 1992

Laboratorios Zambon has launched the opioid receptor antagonist product Antaxone (naltrexone) onto the Spanish market as a treatment for individuals...

Showing 94431-94440 of 95558 articles